Direct Selling Self-Regulatory Council Recommends Daxen Discontinue Certain Health-Related Product Performance Claims

703.247.9330 / press@bbbnp.org

McLean, VA – April 20, 2022 – The Direct Selling Self-Regulatory Council (DSSRC) of BBB National Programs recommended that certain health-related product performance claims made by Daxen, Inc. salesforce be discontinued. Central to this inquiry was a concern that the challenged product performance claims communicated unsupported health-related product performance claims. 

The inquiry was commenced by DSSRC through its ongoing independent monitoring of advertising and marketing claims in the direct selling industry. The claims that were the subject of the inquiry were disseminated by Daxen salesforce members on social media. Daxen is a direct selling company that sells dietary supplements, food and beverages, personal care products, skincare and cosmetics, household products, and a water treatment system.

Product Claims include, but are not limited to:

• (Filipino-language) “Arthritis or Rhuematism: Arthritis or rheumatism or rheumatism arthritis is the inflammation of the joints the soreness and pain and stiffness of the joints or bones are the main symptoms of this disease where the pain worsens as a person gets older…”
• “Alzhermer? Demention? Parkinson? Anxiety? Depression, Mental Disorder? DXN Reishi Powder and Lion’s Mane can help”
• “The first healthy coffee in the world if you take it, it improves your health If you recommend it, improve your pocket 11 powerful reasons to take DXN: 1. Covid-19 2. Diabetes 3. Cancer 4. Tumors 5. Cirrhosis 6. Gastritis 7. Improves vision 8. Alzheimer 9. Obesity 10. Rheumatism 11. Acne

As noted in previous DSSRC cases, health-related claims must be supported by competent and reliable scientific evidence, as defined by the Federal Trade Commission (FTC). DSSRC informed Daxen of its concern that these product claims may convey unsubstantiated health-related and wellness benefits. Daxen did not contest DSSRC’s concerns. 

DSSRC requested that Daxen immediately remove all six social media posts indicating that its products are efficacious against the stated health-related conditions. DSSRC appreciated the company’s commitment to having the subject posts removed from social media, and good faith effort to remove most posts from circulation. 

Though Daxen is an international company with many salesforce members located outside of the United States, DSSRC reminded Daxen that it is nonetheless responsible for the truthfulness and accuracy of product and/or business opportunity claims disseminated by its independent salesforce members. 

Should DSSRC continue to identify social media posts that include claims stating that Daxen products can treat or provide relief from the type of health-related conditions at issue in this inquiry, it will commence a compliance inquiry to evaluate that steps have been taken (including providing salesforce members with access to proper training) to ensure that Daxen salesforce members are not disseminating inaccurate and unauthorized product performance claims.

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of DSSRC decisions, visit the DSSRC Cases and Closures webpage.